Filing Details

Accession Number:
0001225208-22-011073
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-10-21 16:31:38
Reporting Period:
2022-10-19
Accepted Time:
2022-10-21 16:31:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
200406 Johnson & Johnson JNJ Pharmaceutical Preparations (2834) 221024240
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1509999 Peter Fasolo One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08933
Exec Vp, Chief Hr Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-10-19 1,300 $164.50 138,840 No 4 S Direct
Common Stock Disposition 2022-10-19 1,354 $164.50 134,886 No 4 S Direct
Common Stock Disposition 2022-10-19 1,400 $164.50 133,486 No 4 S Direct
Common Stock Disposition 2022-10-19 1,400 $164.50 132,086 No 4 S Direct
Common Stock Disposition 2022-10-19 1,401 $164.50 130,685 No 4 S Direct
Common Stock Disposition 2022-10-19 1,415 $164.50 129,270 No 4 S Direct
Common Stock Disposition 2022-10-19 1,480 $164.50 127,790 No 4 S Direct
Common Stock Disposition 2022-10-19 1,633 $164.50 126,157 No 4 S Direct
Common Stock Disposition 2022-10-19 1,668 $164.50 124,489 No 4 S Direct
Common Stock Disposition 2022-10-19 1,878 $164.50 122,611 No 4 S Direct
Common Stock Disposition 2022-10-19 1,887 $164.50 120,724 No 4 S Direct
Common Stock Disposition 2022-10-19 1,891 $164.50 118,833 No 4 S Direct
Common Stock Disposition 2022-10-19 1,926 $164.50 116,907 No 4 S Direct
Common Stock Disposition 2022-10-19 2,231 $164.50 114,676 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct